Related Experiment Video
Updated: Feb 6, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
Published on: October 17, 2018
Role of Zika Virus prM Protein in Viral Pathogenicity and Use in Vaccine Development
Peter Nambala1, Wen-Chi Su1,2
1Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Abstract:
Recent Zika virus (ZIKV) epidemics necessitate the urgent development of effective drugs and vaccines, which can be accelerated by an enhanced understanding of ZIKV biology. One of the ZIKV structural proteins, precursor membrane (prM), plays an important role in the assembly of mature virions through cleavage of prM into M protein. Recent studies have suggested that prM protein might be implicated in the neurovirulence of ZIKV. Most vaccines targeting ZIKV include prM as the immunogen. Here, we review progress in our understanding of ZIKV prM protein and its application in ZIKV vaccine development.
Insights
Understanding Zika virus precursor membrane (prM) protein is crucial for developing effective vaccines. This review highlights prM
Area of Science:
- Virology and Immunology
- Infectious Diseases
Background:
- Recent Zika virus (ZIKV) epidemics highlight the need for rapid development of medical countermeasures.
- ZIKV precursor membrane (prM) protein is essential for viral particle maturation via cleavage into M protein.
- Emerging evidence suggests a potential role for prM in ZIKV-associated neurovirulence.
Purpose of the Study:
- To review current knowledge regarding the ZIKV prM protein.
- To explore the application of prM in the development of ZIKV vaccines.
Main Methods:
- Comprehensive literature review of studies on ZIKV prM protein.
- Analysis of ZIKV vaccine strategies incorporating prM as an immunogen.
Main Results:
- prM protein is a key structural component involved in ZIKV assembly.
- prM's potential involvement in ZIKV neurovirulence is an active area of research.
- prM is a common component in current ZIKV vaccine candidates.
Conclusions:
- Enhanced understanding of ZIKV prM biology is vital for accelerating vaccine development.
- prM remains a significant target for ZIKV vaccine design and evaluation.
Related Concept Videos
Vaccinations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
What are Viruses?
Viral Structure
Viral Recombination
Role of Proteins in the Human Body

